Curetis Closes EUR 14.5 Million Extension of Series B Financing
- Curetis wins new investors QIAGEN and LSP-HEF, committing EUR 7 million
- Curetis well financed into 2017
Curetis AG, a developer of next-level molecular diagnostic solutions, today announced it has closed a EUR 14.5 million extension of its Series B financing round, which was originally led by HBM…